Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis.
Marczin
N
N
Riedel
B
B
Royston
D
D
Yacoub
M
M
D000403:Airway Resistance / Q000502:physiology; D002196:Capillaries / Q000502:physiology; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008168:Lung / Q000187:drug effects*; D009569:Nitric Oxide / Q000378:metabolism*; D005996:Nitroglycerin / Q000008:administration & dosage / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000502:physiology; D012119:Respiration; D012595:Scleroderma, Systemic / Q000503:physiopathology*; D013990:Tidal Volume / Q000502:physiology; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009569:Nitric Oxide; D005996:Nitroglycerin; D016285:Iloprost